• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

News

Article

The Weekly Roundup: August 7-11

ICYMI, this week we had stories about rising derm stars from the World Congress of Dermatology, secukinumab for pediatric patients with plaque psoriasis, remibrutinib for rapid symptom control of urticaria, and more.

Hyperhidrosis Disease Burden Requires Further Understanding

More understanding of the physical, psychological, and economic burdens of hyperhidrosis is needed.

POLL: At What Age Do Symptoms of Psoriasis Often Start?

This Psoriasis Awareness Month, test your knowledge of the condition. Click here to answer this week's poll.

World Congress of Dermatology 2023: Spotlighting Leaders in Derm

During the 25th World Congress of Dermatology, 40 rising stars and personalities were spotlighted for their contributions to the field.

Study Gives Overview of Effective Treatments for Hidradenitis Suppurativa in Pediatric Patients

Studies showed the various treatments improved symptoms, but more trials need to be done.

Dermatology Partners’ New Office Will Create Jobs and Provide Patient-Centric Care

Clinicians can focus on patient care and leave human resources and bookkeeping to office staff.

Pointers With Portela: Sunscreen FAQs

In this week’s Pointers With Portela, the 208SkinDoc answers frequently asked questions about sunscreen use.

Reviewing Summer Rashes: How Providers Can Spot and Treat

From bug bites to poison ivy, the skin can be exposed to a large spectrum of trouble while patients spend extended time outside.

14-Year-Study Identifies Survival Rates for Patients With Squamous Cell Carcinoma

Clinically asymptomatic patients receiving alternatives to conventional follow-up had a higher 3-year overall survival rate.

FDA Drafts Cosmetic Product Facilities and Listings Guidance

The guidance draft, once finalized, will enable the US FDA to have more oversight in the realm of cosmetic safety.

Digital Health Interventions May Improve Efficacy, Efficiency of Care in Dermatology

Researchers conducted systematic mapping of relevant DHI literature to determine the impact of these interventions on dermatologic care outcomes.

Safety Profile of Secukinumab Favorable for Pediatric Patients With Plaque Psoriasis

In subgroups based on age and bodyweight, treatment with secukinumab did not create new safety signals.

DermiSphere Offers More Affordable Treatment for Full Thickness Skin Loss

A grant from the National Institutes of Health will support continued research to develop products for soft tissue regeneration.

Journal Digest: August 9

This week’s collection of the latest dermatologic studies covers an evaluation of the human stratum corneum with confocal Raman micro-spectroscopy, anti-mBP180 antibodies from mice, an updated review of alopecia areata comorbidities, and an ecchymotic patch related to chronic lymphocytic leukemia.

Promoting Beneficial Skin Care and Self Care Habits Among Teenagers

With hormonal fluctuations, constantly changing schedules, and various afterschool activities, addressing the specific needs of teenage skin becomes essential to promote a lifetime of proper skin care practices.

Countdown to SDPA Fall:​ Reviewing the Top 10 Headlines From SDPA Summer

Dermatology Times is counting down to the annual fall SDPA conference in Nashville, Tennessee, with our top 10 headlines and highlights from this year's summer conference.

In Skin Cancer, Immunotherapy May Lead to Chronic Effects

Research showed that many patients with skin cancer who had been treated using immunotherapy, such as immune checkpoint inhibition, experienced chronic side effects.

LNK01001 Achieves Primary Endpoint in Phase II Trial for Atopic Dermatitis

Patients given LNK01001 showed significant improvement in EASI scores over placebo.

Study Underscores Need for More Effective Psoriasis Oral Therapies

Survey responses revealed the rates and times at which patients switched from oral to biologic therapies.

Microwave Devices Demonstrate Efficacy, Safety in Axillary Hyperhidrosis

The treatments also led to a decrease in the density of immunohistochemistry of sweat glands.

Combination Laser and Recombinant Human Collagen Treatment Improves Periocular Aging

At 3 months post-treatment, skin texture and laxity showed significant improvement.

Remibrutinib Demonstrates Rapid Symptom Control in Phase 3 Trials for Urticaria

The highly selective oral BTK inhibitor is emerging in the treatment landscape as a potential therapeutic option for urticaria uncontrolled by H1-antihistamines.

RescueMD’s Restorative Lip Treatment Supports Healthy Lips Post-Treatment

In a survey, 99% of aesthetic practitioners and professionals said the product made lips look full and healthy.

Genetic Variants Associated With HS Identified

Genetic variants associated with hidradenitis suppurativa (HS) were identified, although a causal effect is not proven.

Empower Your Youngest Patients This School Year

Back-to-school season is an opportunity for dermatology clinicians to empower pediatric, adolescent, and young adult patients with treatment solutions for diagnoses including acne, atopic dermatitis, and skin cancer.

Study Shows Lupus Band Test Can Be Useful In Diagnosing Lupus Erythematosus

Investigators wanted to find a testing option if other parameters are negative or conflicting and LE is suspected.


Related Videos
3 experts are featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.